Stereotactic needle biopsy and laser ablation of geographically distinct lesions through a novel magnetic resonance imaging–compatible cranial stereotaxic frame: illustrative case

Youssef J Hamade, Avanti Mehrotra, Clark C. Chen

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

BACKGROUND Current technologies that support stereotactic laser ablation (SLA) of geographically distinct lesions require placement of multiple bolts or time-consuming, intertrajectory adjustments. OBSERVATIONS Two geographically distinct nodular lesions were safely biopsied and laser ablated in a 62-year-old woman with recurrent glioblastoma using the ClearPoint Array frame, a novel magnetic resonance imaging–compatible stereotactic frame designed to support independent parallel trajectories without intertrajectory frame adjustment. LESSONS Here, the authors provide a proof-of-principle case report demonstrating that geographically distinct lesions can be safely biopsied and ablated through parallel trajectories supported by the ClearPoint Array frame without intertrajectory adjustment.

Original languageEnglish (US)
Article numberCASE22448
JournalJournal of Neurosurgery: Case Lessons
Volume5
Issue number2
DOIs
StatePublished - Jan 2023

Bibliographical note

Publisher Copyright:
© 2023 The authors,.

Keywords

  • brain tumor
  • glioblastoma
  • laser ablation
  • stereotactic needle biopsy

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Stereotactic needle biopsy and laser ablation of geographically distinct lesions through a novel magnetic resonance imaging–compatible cranial stereotaxic frame: illustrative case'. Together they form a unique fingerprint.

Cite this